Addus HomeCare at Jefferies Conference: Strategic Expansion in Texas

Addus HomeCare (ADUS) presented at the Jefferies 2025 Healthcare Services Conference, reaffirming its target of 10% annual growth, driven by strategic acquisitions, like the successful integration of Gentiva's personal care business, and ongoing technological advancements. While Medicaid redeterminations have presented a temporary headwind, the company anticipates a return to normalized growth by 2026, with new admissions now exceeding discharges in key markets. Addus is strategically engaging in value-based contracts, positioning its home-based care services as a cost-effective alternative for states and managed care organizations by demonstrating significant reductions in emergency room visits and readmissions, thereby addressing potential Medicaid budget pressures.

Analysis

Addus HomeCare (ADUS) has articulated a clear growth framework targeting 10% annual growth, evenly split between organic expansion and acquisitions. The recent integration of Gentiva's personal care business is proceeding smoothly and has strategically positioned ADUS as the market leader in Texas and Arkansas, providing a substantial runway for M&A in the large Texas market where it currently holds only a 5% share. While top-line growth has been temporarily muted by the operational drag of Medicaid redeterminations, management provided a clear timeline for recovery, noting that new client starts are already exceeding discharges in New Mexico and Texas, with Illinois expected to follow in Q4 2025, setting the stage for a return to normalized growth by 2026. The company is proactively mitigating macro risks by positioning itself as a cost-saving solution for state budgets, leveraging its value proposition that home care is two to three times less expensive than facility-based care. This is further strengthened by its expansion into value-based contracts with managed care organizations, where it has demonstrated an ability to reduce ER visits and hospital readmissions. Operational efficiency is being pursued through technology, including a caregiver app now at 86% adoption in Illinois and the use of AI to accelerate hiring, addressing key challenges in labor retention and recruitment.

Key Decisions for Investors

• Investors should monitor admission and discharge trends in Illinois during Q4, as a positive crossover would validate management's timeline for a return to normalized organic growth across its key markets by 2026.
• Consider the company's dual growth strategy; while half of the 10% annual growth target relies on acquisitions, further margin expansion is contingent on realizing synergies, such as the EMR integration of the Gentiva business planned for late 2026.
• The strategic shift towards value-based contracts with managed care organizations should be viewed as a key defensive characteristic, potentially insulating ADUS from broader Medicaid reimbursement pressures by proving its ability to lower total healthcare costs.
• The successful implementation of technology like the caregiver app and AI in hiring are critical indicators to watch for, as they directly impact the company's ability to manage labor costs, reduce turnover, and drive operating leverage.